ArticleBMC microbiology2025
Prevalence and emm typing of multi-drug resistant Streptococcus pyogenes in tertiary care health settings.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Differential Roles of Ag and ZnO in the Bactericidal Activity of Ag/ZnO-Hydroxyapatite Nanocomposites against Multidrug-Associated Methicillin-Resistant Staphylococcus aureus.Current microbiology · 2026Article
- Molecular Characterization ofMicroorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundStreptococcus pyogenes causes diverse infections, including pharyngitis and invasive diseases. Emerging resistance to β-lactams and macrolide poses a significant public health threat in developing countries. This study examines the prevalence, antibiotic susceptibility, and emm types of S. pyogenes strains isolated from hospitals in Khyber Pakhtunkhwa (KP), Pakistan.
methodsA total of 4,062 clinical samples, including throat swabs, blood, pus, and biopsies, were collected from eight hospitals. S. pyogenes was isolated and identified using standard microbiological techniques. Antibiotic susceptibility tests and Minimum Inhibitory Concentrations (MIC) were investigated using the disc diffusion method and Epsilometer test (E-test), respectively. PCR and DNA sequencing were used to determine the emm typing of the isolates.
resultsOf the 4,062 samples, 471 were positive for S. pyogenes (11.5%). The most common emm types identified were emm12 (16%), emm4 (13%), and emm1 (12%). Isolates from the throat samples predominantly yielded emm1. However, emm12 was most common in biopsy and blood samples, and emm4 was frequently isolated from pus. High resistance to erythromycin (8%) and tetracycline (8%) and no resistance to meropenem, vancomycin, and teicoplanin were recorded. Penicillin resistance ranged from 0.6% to 7.2%, with MIC distribution between 0.07-2.9 mg/L. Factors including low financial status (AOR = 3.18, 95% CI = 1.60-6.32, P = 0.05), self-medication with unprescribed antibiotics (AOR = 5.45, 95% CI = 2.60-11.22, P = 0.04), and presence of comorbidities (AOR = 9.13, 95% CI = 2.54-26.54, P = 0.03) were significantly associated with increased risk of infection.
conclusionThe emm typing results revealed significant genetic diversity among S. pyogenes isolates, with emm12, emm4, and emm1 being the most prevalent types in KP. This diversity, along with the observed antibiotic resistance patterns, underscores the need for ongoing surveillance and targeted treatment strategies to effectively manage S. pyogenes infections in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.